Author

Richard Graham

THE INTESTINALLY RESTRICTED, ORALLY ADMINISTERED, PAN-JAK INHIBITOR TD-1473 DEMONSTRATES FAVORABLE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND SIGNAL FOR CLINICAL ACTIVITY IN SUBJECTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS

William Sandborn, Raj Bhandari, Jonathan A. Leighton, Ravi Ganeshappa, Deanna Nguyen, Brian Ferslew, Ann Olmsted, Richard Graham, Julian Panés

Item 1 - 1 / 1
1